"nonadenoid" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "non",
        "3": "adenoid"
      },
      "expansion": "non- + adenoid",
      "name": "prefix"
    }
  ],
  "etymology_text": "non- + adenoid",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "nonadenoid (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with non-",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "1912, The Annals of Otology, Rhinology & Laryngology, page 834",
          "text": "If one compares results obtained from observations of the hypophysis of nonadenoid children of the same age, it is evident that there existed from the above histologic report a hypersecretion and a hyperplasia of the glandular (adenomatous) tissue in the adenoid type.",
          "type": "quotation"
        },
        {
          "ref": "2017, Derek Raghavan, Manmeet S. Ahluwalia, Charles D. Blanke, Textbook of Uncommon Cancer, page 137",
          "text": "For patients at high risk of recurrence in this setting, we would consider radiosensitizing chemotherapy with cisplatin either at a high dose of 100mg/m² every 3 weeks or as weekly therapy at a lower dose of 40mg/m²/week for nonadenoid cystic carcinomas.",
          "type": "quotation"
        },
        {
          "ref": "2020, Gregory M. M. Videtic, Andrew D. Vassil, Neil M. Woody, Handbook of Treatment Planning in Radiation Oncology, page 60",
          "text": "For high-grade, N0 tumors (nonadenoid cystic histology): consider electively treating levels Ib, II, III",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Not adenoid."
      ],
      "id": "en-nonadenoid-en-adj-ZmPcMIC3",
      "links": [
        [
          "adenoid",
          "adenoid"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "nonadenoid"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "non",
        "3": "adenoid"
      },
      "expansion": "non- + adenoid",
      "name": "prefix"
    }
  ],
  "etymology_text": "non- + adenoid",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "nonadenoid (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with non-",
        "English terms with quotations",
        "English uncomparable adjectives"
      ],
      "examples": [
        {
          "ref": "1912, The Annals of Otology, Rhinology & Laryngology, page 834",
          "text": "If one compares results obtained from observations of the hypophysis of nonadenoid children of the same age, it is evident that there existed from the above histologic report a hypersecretion and a hyperplasia of the glandular (adenomatous) tissue in the adenoid type.",
          "type": "quotation"
        },
        {
          "ref": "2017, Derek Raghavan, Manmeet S. Ahluwalia, Charles D. Blanke, Textbook of Uncommon Cancer, page 137",
          "text": "For patients at high risk of recurrence in this setting, we would consider radiosensitizing chemotherapy with cisplatin either at a high dose of 100mg/m² every 3 weeks or as weekly therapy at a lower dose of 40mg/m²/week for nonadenoid cystic carcinomas.",
          "type": "quotation"
        },
        {
          "ref": "2020, Gregory M. M. Videtic, Andrew D. Vassil, Neil M. Woody, Handbook of Treatment Planning in Radiation Oncology, page 60",
          "text": "For high-grade, N0 tumors (nonadenoid cystic histology): consider electively treating levels Ib, II, III",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Not adenoid."
      ],
      "links": [
        [
          "adenoid",
          "adenoid"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "nonadenoid"
}